title: Fibrinolytic inhibitors and fibrin characteristics determine a hypofibrinolytic state in patients with pulmonary embolism.
authors.forename: Anna Paola
authors.initials: AP
authors.lastname: Cellai
authors.forename: Donatella
authors.initials: D
authors.lastname: Lami
authors.forename: Emilia
authors.initials: E
authors.lastname: Antonucci
authors.forename: Claudia
authors.initials: C
authors.lastname: Fiorillo
authors.forename: Matteo
authors.initials: M
authors.lastname: Becatti
authors.forename: Benedetta
authors.initials: B
authors.lastname: Olimpieri
authors.forename: Daniele
authors.initials: D
authors.lastname: Bani
authors.forename: Elisa
authors.initials: E
authors.lastname: Grifoni
authors.forename: Caterina
authors.initials: C
authors.lastname: Cenci
authors.forename: Rossella
authors.initials: R
authors.lastname: Marcucci
authors.forename: Lucia
authors.initials: L
authors.lastname: Mannini
authors.forename: Daniela
authors.initials: D
authors.lastname: Poli
authors.forename: Rosanna
authors.initials: R
authors.lastname: Abbate
authors.forename: Domenico
authors.initials: D
authors.lastname: Prisco
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000494:pharmacology*; D001780:Blood Coagulation Tests / Q000379:methods; D005260:Female; D005337:Fibrin / Q000737:chemistry*; D005340:Fibrinogen / Q000378:metabolism; D005342:Fibrinolysis; D006801:Humans; D008297:Male; D008875:Middle Aged; D011655:Pulmonary Embolism / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology*; D012307:Risk Factors; D020246:Venous Thrombosis / Q000150:complications / Q000503:physiopathology
chemical_list: D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D005337:Fibrin; D005340:Fibrinogen